Rohto Pharmaceutical Joins Hands with Pharma Foods International.Tokyo Tokyo (tō`kēō), city (1990 pop. 8,163,573), capital of Japan and of Tokyo prefecture, E central Honshu, at the head of Tokyo Bay. , Japan, Sept 21, 2005 - (JCNN JCNN Japan Corporate News Network ) - Rohto Pharmaceutical has agreed with Pharma Foods International on joint development and equity participation. Under the agreement terms, the two companies will strive to develop materials for functional foods and medicines based on the IgY (egg yolk yolk (yok) the stored nutrient of an oocyte or ovum. yolk n. The portion of the egg of an animal that consists of protein and fat from which the early embryo gets its main nourishment and of antibody) technology. Further, Rohto undertook a private placement of 1,000 common stocks (a 23% stake) offered by Pharma Foods as of September 15. Through this placement, the two companies aim to proactively promote joint development efforts while improving their respective corporate values. Pharma Foods International is a Kyoto-based bio-venture company that specializes in developing functional materials targeting immune systems immune system Cells, cell products, organs, and structures of the body involved in the detection and destruction of foreign invaders, such as bacteria, viruses, and cancer cells. Immunity is based on the system's ability to launch a defense against such invaders. and aging and nervous systems. With the latest move, Rohto will accelerate its drive to develop proprietary functional foods. Source: JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) http://www.japancorp.net Copyright [c] 2005 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion